Comparison of methods for determining renal function decline in early autosomal dominant polycystic kidney disease: the consortium of radiologic imaging studies of polycystic kidney disease cohort.
about
Accuracy and limitations of equations for predicting the glomerular filtration rate during follow-up of patients with non-diabetic nephropathiesInterventions for preventing the progression of autosomal dominant polycystic kidney diseaseA systematic review of the predictors of disease progression in patients with autosomal dominant polycystic kidney diseaseTolvaptan in Patients with Autosomal Dominant Polycystic Kidney DiseaseCyst infection in hospital-admitted autosomal dominant polycystic kidney disease patients is predominantly multifocal and associated with kidney and liver volumeThe influence of renal manifestations to the progression of autosomal dominant polycystic kidney diseaseMedical resource utilization and costs associated with autosomal dominant polycystic kidney disease in the USA: a retrospective matched cohort analysis of private insurer data.Low-dose rapamycin (sirolimus) effects in autosomal dominant polycystic kidney disease: an open-label randomized controlled pilot study.Performance of the CKD-EPI Equation to Estimate GFR in a Longitudinal Study of Autosomal Dominant Polycystic Kidney DiseaseMeasuring and estimating GFR and treatment effect in ADPKD patients: results and implications of a longitudinal cohort study.Demographic and clinical characteristics associated with glomerular filtration rates in living kidney donorsPotentially modifiable factors affecting the progression of autosomal dominant polycystic kidney disease.Diagnostic Algorithm in the Management of Acute Febrile Abdomen in Patients with Autosomal Dominant Polycystic Kidney Disease.Sex difference in urine concentration across differing ages, sodium intake, and level of kidney disease.Relationship of copeptin, a surrogate marker for arginine vasopressin, with change in total kidney volume and GFR decline in autosomal dominant polycystic kidney disease: results from the CRISP cohortA comparison of change in measured and estimated glomerular filtration rate in patients with nondiabetic kidney disease.Kidney volume and function in autosomal dominant polycystic kidney disease.The applicability of eGFR equations to different populations.Review of tolvaptan for autosomal dominant polycystic kidney disease.Clinical Trials and a View Toward the Future of ADPKD.Iohexol plasma clearance for measuring glomerular filtration rate in clinical practice and research: a review. Part 2: Why to measure glomerular filtration rate with iohexol?Diagnostic Evaluation as a Biomarker in Patients with ADPKD.ADPKD: clinical issues before and after renal transplantation.Performance of glomerular filtration rate estimating equations in a community-based sample of Blacks and Whites: the multiethnic study of atherosclerosis.Clinicians' attitude towards family planning and timing of diagnosis in autosomal dominant polycystic kidney disease.Role of coronary artery calcification score on the decrease in GFR among subjects with CT coronary angiography.
P2860
Q21558546-41025B86-0960-4D5F-8953-7DB0526B3369Q24186484-1D76F585-881C-4A59-B088-CA1DDE0192E2Q26798115-71AC0350-A44E-4D11-BA5B-B1EAD94770B5Q29037884-52B01538-091C-4511-A071-6F058C567C89Q30432848-D214FF62-4D65-458E-8D46-2F60F1EE0BACQ30485303-696079A4-00D4-47F6-BDB8-8CFBBA05853BQ30908446-BA560D6E-B73E-4896-A229-5309945F17E9Q33571758-89D4CA1A-B65F-4877-A809-C4D8A5DA40FFQ33873062-2F9971DA-602C-491D-9DD0-3474202390FCQ34185922-981E0A99-227C-47FA-811B-157EE77B7E9BQ34658067-38DC7679-BBEA-4BBB-9B0E-4016FCD424ADQ34858052-A60EB20E-9F54-43F2-859B-F7AA64C8CDCEQ36104948-580D29C1-C80D-41D2-BE00-35B6C388F275Q36600774-347D7CEA-D499-4D5B-B1EA-FAF23FAD62BCQ36616057-A99C41DA-C27E-4B65-9893-71BE23171C36Q36843484-2CFCBB25-5890-41BD-9676-78CB2BEEBC49Q37581497-418B92F1-B28E-4B96-AF26-3D502F6B27F3Q38121765-585AAAA4-EC41-43E8-97B3-9589FE867BDDQ38202613-F7593BBF-8D0C-48FD-8F86-333132C92EC0Q38812543-6F60FD36-C13A-4535-BDAA-E788ADC5C00BQ38966669-D3DD8E4F-0916-4832-AB5C-8DE82A9744ABQ38978474-8BB61370-9436-498C-ACC6-4895B2B7473CQ38987102-CB6CBB16-51FA-468D-9590-7B4E9B519C36Q40201016-5F587CA6-2ADF-46F4-9A69-CD2DE1C0F31BQ42367550-4B548D62-A373-424F-8D77-ABC805D42925Q51174148-7449F989-8F3E-4926-94EE-9002AB12F39E
P2860
Comparison of methods for determining renal function decline in early autosomal dominant polycystic kidney disease: the consortium of radiologic imaging studies of polycystic kidney disease cohort.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Comparison of methods for dete ...... ycystic kidney disease cohort.
@en
Comparison of methods for dete ...... ycystic kidney disease cohort.
@nl
type
label
Comparison of methods for dete ...... ycystic kidney disease cohort.
@en
Comparison of methods for dete ...... ycystic kidney disease cohort.
@nl
prefLabel
Comparison of methods for dete ...... ycystic kidney disease cohort.
@en
Comparison of methods for dete ...... ycystic kidney disease cohort.
@nl
P2093
P356
P1476
Comparison of methods for dete ...... ycystic kidney disease cohort.
@en
P2093
Andrew D Rule
Arlene B Chapman
CRISP Consortium
Catherine M Meyers
J Philip Miller
Jared J Grantham
Kyongtae T Bae
Lisa M Guay-Woodford
Paul A Thompson
Saulo Klahr
P304
P356
10.1681/ASN.2005070697
P577
2006-02-01T00:00:00Z